You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The startup has exclusively licensed an integration engine from the University of Miami to augment its VIPER platform and improve trial recruitment specifically in precision oncology.
In PNAS this week: single-cell RNA sequencing study of pancreatic duct cells, sequencing of viruses affecting honey bees, and more.
The molecular assay is expected to require a pharyngeal throat swab to deliver diagnostic results on a paper strip in under 30 minutes.
The findings implicated immune response, lipid metabolism, tau binding proteins, and amyloid precursor protein metabolism pathways in disease risk.
In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.
Investigators from the school will use the funding to continue a research program applying genomics to hearing loss screening and treatment.
New trial data presented at ASCO highlights the utility of checkpoint inhibitors, alone or with chemotherapy, across PD-L1 expression groups.
A panel at the Biology of Genomes meeting discussed the ethical, legal, and social ramifications of germline gene editing.
US researchers conducted a genome-wide association study of sexual orientation among men, but found only tentative links.
The HPOs will receive $13.8 million to enroll people interested in the All of Us program, gather participant health information, and help retain participants.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.